KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Gross Profit: 2020-2025

Historic Gross Profit for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $30.7 million.

  • Ginkgo Bioworks Holdings' Gross Profit fell 61.22% to $30.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.5 million, marking a year-over-year decrease of 21.48%. This contributed to the annual value of $188.5 million for FY2024, which is 8.02% down from last year.
  • According to the latest figures from Q3 2025, Ginkgo Bioworks Holdings' Gross Profit is $30.7 million, which was down 23.66% from $40.2 million recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Gross Profit ranged from a high of $79.1 million in Q3 2024 and a low of -$126.1 million during Q1 2023.
  • In the last 3 years, Ginkgo Bioworks Holdings' Gross Profit had a median value of $36.3 million in 2024 and averaged $15.1 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Gross Profit plummeted by 712.43% in 2022, and later skyrocketed by 160.14% in 2023.
  • Ginkgo Bioworks Holdings' Gross Profit (Quarterly) stood at -$13.6 million in 2021, then tumbled by 712.43% to -$110.4 million in 2022, then surged by 132.28% to $35.6 million in 2023, then climbed by 1.88% to $36.3 million in 2024, then plummeted by 61.22% to $30.7 million in 2025.
  • Its Gross Profit stands at $30.7 million for Q3 2025, versus $40.2 million for Q2 2025 and $40.4 million for Q1 2025.